NCT02495077 Effects of Inhibiting Early Inflammation in Kidney Transplant Patients Status COMPLETED Phase PHASE2
NCT02494921 LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC Status COMPLETED Phase PHASE1/PHASE2
NCT02486952 MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma Status COMPLETED Phase N/A
NCT02485691 Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent Status COMPLETED Phase PHASE4
NCT02481310 Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma Status UNKNOWN Phase PHASE1/PHASE2
NCT02474563 Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma Status COMPLETED Phase N/A
NCT02463331 Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial Status COMPLETED Phase PHASE4
NCT02457221 A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis Status COMPLETED Phase PHASE3
NCT02453009 Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT02451748 IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA Status COMPLETED Phase PHASE4
NCT02449278 The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE3
NCT02449265 Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma Status RECRUITING Phase PHASE3
NCT02449252 Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma Status RECRUITING Phase PHASE3
NCT02428751 R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell Lymphoma Status UNKNOWN Phase PHASE3
NCT02420717 Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE2
NCT02419469 Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Status TERMINATED Phase PHASE2
NCT02414568 Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin Status COMPLETED Phase PHASE2
NCT02406092 Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A Status COMPLETED Phase PHASE3
NCT02386735 Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD Status TERMINATED Phase NA